Compound details
Epomusenin B
| Compound ID | CDAMM01257 |
|---|---|
| Common name | Epomusenin B | IUPAC name | 2-methyl-4-[12-(3-octadec-3-enyloxiran-2-yl)dodecyl]-2H-furan-5-one |
| Molecular formula | C37H66O3 |
| Retention time | 21.02 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 559.504 | Theoretical mz | 559.508 |
| Error | 8.18 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.7353 |
| Inchi key | MKKPDARISYEUBT-FLFQWRMENA-N |
|---|---|
| Smiles | O=C1OC(C=C1CCCCCCCCCCCCC2OC2CCC=CCCCCCCCCCCCCCC)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SEA |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SEA |
| Q99685 | MGLL | Monoglyceride lipase | T18664 | SEA |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SEA |
| Q9Y4D2 | DAGLA | Sn1-specific diacylglycerol lipase alpha | T03150 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T18664 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q99685 | MGLL |
| T18664 | DI0409 | Tic disorder | [ICD-11: 8A05] | Q99685 | MGLL |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |